How do you pay?

How to pay the least

From

$12.45 for 30 capsules delivered ($7.20 plus $5.25 shipping)

Generic calcitriol from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic calcitriol. It comes by mail.

Need it today? From $15.64 for 30 capsules with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.

See the price and get the card 

With a membership From $9.13 for 30 capsules from Amazon Pharmacy, by mail ($139 a year).

Open Amazon Pharmacy 

A regular generic has the same active ingredient as Rocaltrol, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameRocaltrol
Authorized genericcalcitriol
Regular genericcalcitriol
What you’d pay
Not soldNo longer sold
Cash priceAsk the pharmacyOften less than Rocaltrol
From$12.45for 30 capsules at Cost Plus Drugs, with shipping
Same as Rocaltrol?
–
Same medicine
Same active ingredientFillers and dyes can differ

Brand nameNot sold

Rocaltrol itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.

See the authorized generic →

Authorized genericThe NDC to ask for

The same medicine as Rocaltrol, without the brand name. Give the pharmacy its NDC to get it.

calcitriol

Sold by
  • ANI PharmaceuticalsMade by Esjay Pharma, the company behind Rocaltrol
NDC to ask for
  • 1 mcg/mLsolution
    • 70954-831-1011-digit: 70954-0831-1015 mL per bottle

Source: FDA, updated October 30, 2026

What to say at the pharmacy

“Before you fill my Rocaltrol, can you tell me what I’d pay for the brand, for the authorized generic from ANI Pharmaceuticals (NDC 70954-831-10), and for a regular generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

Brand and authorized generic labels

Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).

Rocaltrol itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.

Authorized genericANI Pharmaceuticals
See the ingredients

Active: calcitriol 1 mcg/mL

Inactive:

  • Butylated hydroxyanisole
  • Butylated hydroxytoluene
  • Medium-chain triglycerides

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic calcitriol, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

8 companies sell a generic of Rocaltrol that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Avet PharmaceuticalsCapsule 0.25 mcg, 0.5 mcg

    Has dyes: FD&C Red No. 3, FD&C Yellow No. 6 · Made by Onesource Specialty Pharma

    Product page on avetpharma.com

    How it looks, what’s in it, NDCs

    0.25 mcg Orange, oval, 10 mm, marked “673”

    PackageNDC
    Bottle of 3023155-662-03
    Bottle of 10023155-662-01

    0.5 mcg Orange, capsule, 13 mm, marked “674”

    PackageNDC
    Bottle of 10023155-663-01

    Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, glycerin, sorbitol, FD&C Yellow No. 6, FD&C Red No. 3, titanium dioxide, propylene glycol, shellac, isopropyl alcohol, butyl alcohol, ammonia, ferrosoferric oxide

    FDA label

  • BionpharmaCapsule 0.25 mcg, 0.5 mcg

    Has dyes: FD&C Red No. 40, FD&C Yellow No. 6

    Product page on bionpharma.com

    How it looks, what’s in it, NDCs

    0.25 mcg Light orange, oval, 10 mm, marked “CAL1”

    PackageNDC
    Bottle of 3069452-207-13
    Bottle of 10069452-207-20

    0.5 mcg Dark orange-red, oval, 10 mm, marked “CAL2”

    PackageNDC
    Bottle of 3069452-208-13
    Bottle of 10069452-208-20

    Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, gelatin, glycerin, sorbitol, sorbitan, mannitol, water, FD&C Yellow No. 6, FD&C Red No. 40, titanium dioxide, ferrosoferric oxide

    FDA label

  • Chartwell RXCapsule 0.25 mcg, 0.5 mcg

    Has dyes: FD&C Red No. 3, FD&C Yellow No. 6 · Made by Onesource Specialty Pharma

    How it looks, what’s in it, NDCs

    0.25 mcg Orange, oval, 10 mm, marked “673”

    PackageNDC
    Bottle of 9062135-610-90

    0.5 mcg Orange, capsule, 13 mm, marked “674”

    PackageNDC
    Bottle of 9062135-611-90

    Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, glycerin, sorbitol, FD&C Yellow No. 6, FD&C Red No. 3, titanium dioxide

    FDA label

  • Epic PharmaCapsule 0.25 mcg, 0.5 mcg

    Has a dye: FD&C Yellow No. 6 · Made by Humanwell Puracap Pharmaceutical Wuhan

    Product page on epic-pharma.com

    How it looks, what’s in it, NDCs

    0.25 mcg Opaque light orange, capsule, 9 mm, marked “P1”

    PackageNDC
    Bottle of 10042806-732-01

    0.5 mcg Opaque light orange, capsule, 12 mm, marked “P2”

    PackageNDC
    Bottle of 10042806-733-01

    Inactive ingredients: butylated hydroxytoluene, medium-chain triglycerides, glycerin, noncrystallizing sorbitol solution, butylated hydroxyanisole, gelatin, FD&C Yellow No. 6, titanium dioxide, alcohol

    FDA label

  • Hikma PharmaceuticalsSolution 1 mcg/mL
    How it looks, what’s in it, NDCs

    1 mcg/mL

    PackageNDC
    Carton of 15 mL0054-3120-41

    Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, omega-3-acid ethyl esters

    FDA label

  • Rising Pharma HoldingsSolution 1 mcg/mL
    How it looks, what’s in it, NDCs

    1 mcg/mL

    PackageNDC
    Carton of 15 mL64980-447-15

    Inactive ingredients: medium-chain triglycerides, butylated hydroxyanisole, butylated hydroxytoluene

    FDA label

  • Strides Pharma ScienceCapsule 0.25 mcg, 0.5 mcg

    Has dyes: FD&C Red No. 3, FD&C Yellow No. 6 · Made by Onesource Specialty Pharma

    Product page on stridespharmausa.com

    How it looks, what’s in it, NDCs

    0.25 mcg Orange, oval, 10 mm, marked “673”

    PackageNDC
    Container of 3064380-723-04
    Container of 10064380-723-06

    0.5 mcg Orange, capsule, 13 mm, marked “674”

    PackageNDC
    Container of 10064380-724-06

    Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, glycerin, noncrystallizing sorbitol solution, FD&C Yellow No. 6, FD&C Red No. 3, titanium dioxide, propylene glycol, shellac, ferrosoferric oxide, isopropyl alcohol, butyl alcohol, ammonia

    FDA label

  • Teva PharmaceuticalsCapsule 0.25 mcg, 0.5 mcg

    Being phased out; sold until February 2027

    How it looks, what’s in it, NDCs

    0.25 mcg Red-brown and yellow-brown, oval, 10 mm, marked “93 / 657”

    PackageNDC
    Bottle of 1000093-7352-01

    0.5 mcg Brown and pink, oval, 13 mm, marked “93 / 658”

    PackageNDC
    Bottle of 1000093-7353-01

    Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, gelatin, glycerin, mannitol, ferric oxide red, sorbitol, titanium dioxide, ferric oxide yellow, propylene glycol

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Predialysis Patients

Calcitriol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥ 100 pg/mL is strongly suggestive of secondary hyperparathyroidism.

Dialysis Patients

Calcitriol is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization.

Hypoparathyroidism Patients

Calcitriol is also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism.

Source: the FDA label for Calcitriol (ANI Pharmaceuticals, Inc.), July 10, 2026. Full label on DailyMed 

Good to know